Novo Nordisk Partner Sued by Investors
Novo Nordisk is involved in two lawsuits. One is from shareholders about a drug trial. The other is a U.S. lawsuit about insulin distribution.
A U.S. judge ordered Novo Nordisk to answer questions in a lawsuit. The lawsuit says the company gave false information about a drug called CagriSema. This drug is for obesity and diabetes. Another lawsuit is being filed by U.S. authorities. It is about how Novo Nordisk distributes insulin in America. This could change how the company works and how much it costs.
Summarized from the sources above. Read the originals for the full story.
Highlights
Novo Nordisk Faces Shareholder Lawsuit
Shareholders are suing Novo Nordisk about a clinical trial.
Judge Orders Novo Nordisk Response
A U.S. judge said Novo Nordisk must answer part of the lawsuit.
CagriSema Trial Allegations
The lawsuit claims Novo Nordisk misled investors about CagriSema.
US Lawsuit Against Novo Nordisk Partner
U.S. authorities are suing a Novo Nordisk partner.
Insulin Distribution Lawsuit
The lawsuit concerns violations of U.S. law about insulin distribution.